BioHealth News
With $66.7M in Fresh Funding, Virginia Plans for Major Life Science, Biotech, and Biopharma Expansion · BioBuzz
Governor Glenn Youngkin has announced the approval of over $66 million in state grants for four projects in the Biotechnology, Life Sciences, and Pharmaceutical…
Read More
TEDCO Invests SSBCI Funds in JuneBrain
Maryland business dedicated to developing telehealth solutions for remotely monitoring patients with eye and brain diseases COLUMBIA, Md. (February 16, 2023) – TEDCO, Maryland’s…
Read More
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian…
Read More
Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use
If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use…
Read More
BioHealth Innovation Appoints Dr. Michael Friedlander of Virginia Tech to Board of Directors
The commitment and mission of growing the BioHealth Capital Region is being continued with new board member ROCKVILLE, MARYLAND, February 14, 2023 – The Board…
Read More
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax’ COVID-19 Vaccine
Modified agreement also includes the development of an updated vaccine in fall 2023 GAITHERSBURG, Md., Feb. 13, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq:…
Read More
Here Are the Top Research Skills Life Science Employers Are Looking For in 2023 · BioBuzz
By Sarah Ellinwood with contributions by Mark Nardone, Chris Frew, Sean Rae, Laura Frew, Jeff Caskey, and Heather Mudrick February 9, 2023 If you…
Read More
Meet the NIA Entrepreneur-in-Residence (EIR)
ATTN Awardees: #DYK that #NIAsbir has #Entrepreneurs-in-Residence? Our #EIRs, Diane Ignar, Ph.D., R.Ph., and John P. Reinhart, CPA, M.B.A., bring unique expertise and experience…
Read More
New $60 M research translation and tech transfer effort from NSF
I want to share our team at NSF's $60 M initiative focused on driving more research translation out of universities, with a specific focus…
Read More
Lessons in Raising Capital: A Look at Financing Strategy and Approach
Many parties are involved when a life sciences startup is raising capital. This program will explore strategic and tactical considerations of equity financing for…
Read More
Celebrating Rare Disease Day and 40 Years of the Orphan Drug Act Advocating for Rare Disease Patients and Their Families
HERNDON, VA. (PRWEB) FEBRUARY 08, 2023 Global life expectancy has more than doubled over the last two centuries, from less than 30 years to…
Read More
Policy Changes Could Cut Short a Golden Age of Drug Development | RealClearPolicy
2022 was an incredibly productive year for American scientists. Biopharmaceutical researchers conducted over 7,000 clinical programs, including more than 3,000 for cancer, 182 for…
Read More
Issue Brief: March-In Rights Under the Bayh-Dole Act (February 2023)
The biggest controversy surrounding the Bayh-Dole Act — which allows academic institutions and private contractors to own and manage inventions they make with federal funds…
Read More
ApogeeBio Postdoctoral Programme
Dear scientific community, The European programme ApogeeBio has launched the 2nd international call for 12 postdoctoral positions in Genopole biocluster, Paris region (FR). It…
Read More
Baltimore’s KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product · BioBuzz
KaloCyte’s experimental synthetic red blood cell product ErythroMer could provide a solution to the high need for treating trauma in both military and civilian…
Read More